Lobbying

Wake Forest Baptist Medical Center Affiliate of Advocate Health's latest lobbying report covers Q4 2025, at $20K. The four quarters Q4 2025–Q3 2026 total $20K. Its first report covers Q1 2023; the issues it reports most are Health Issues and Medicare/Medicaid.

Wake Forest Baptist Medical Center Affiliate of Advocate Health

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$20K
Last 4 quarters
vs last quarter
No record
Q3 2026 against the quarter before
First report
Q1 2023
The first quarter a report named it

Lobbying by quarter

Wake Forest Baptist Medical Center Affiliate of Advocate Health lobbying by quarter
Wake Forest Baptist Medical Center Affiliate of Advocate Health lobbying by quarter
QuarterAmountReports
Q1 2023$13.5K1
Q2 2023$30.6K1
Q3 2023$23.1K1
Q4 2023$24.1K1
Q1 2024$30K1
Q2 2024$110K1
Q3 2024$110K1
Q4 2024$23K1
Q1 2025$20K1
Q2 2025$20K1
Q3 2025$20K1
Q4 2025$20K1
Q1 2026$00
Q2 2026$00
Q3 2026$00

By issue

  • Health issues$93.8K · 12 reports
  • Medicare and Medicaid$91.1K · 11 reports
  • Education$63.8K · 9 reports
  • Labor, antitrust and workplace$63.8K · 9 reports
  • Pharmacy$63.8K · 9 reports
  • Telecommunications$61.1K · 8 reports
  • Budget and appropriations$7,072 · 2 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • HOUSE OF REPRESENTATIVES12 reports
  • SENATE12 reports
  • Centers For Medicare and Medicaid Services (CMS)7 reports

Firms it paid

Firm
In-houseWake Forest Baptist Medical Center Affiliate of Advocate Health$444.3K12 quarters

Former officials lobbying for it

No lobbyist with a covered position.

Lobbying reports

Filed by
01/20for Q4 2025In-house$20K
25/10/15for Q3 2025In-house$20K
25/07/21for Q2 2025In-house$20K
25/04/17for Q1 2025In-house$20K
25/01/17for Q4 2024In-house$23K
24/10/17for Q3 2024In-house$110K
24/07/19for Q2 2024In-house$110K
24/04/19for Q1 2024In-house$30K
24/02/05for Q4 2023In-house$24.1K
23/10/20for Q3 2023In-house$23.1K
23/07/19for Q2 2023In-house$30.6K
23/04/20for Q1 2023In-house$13.5K
23/01/30for Q1 2023In-houseUnder $5,000